Provided is a pre-filled drug package that can inhibit protein aggregation after long-term storage even when accommodating a protein solution formulation having a low non-ionic surfactant concentration. The pre-filled drug package includes a protein solution formulation and a housing accommodating the protein solution formulation. The protein solution formulation has a non-ionic surfactant concentration of not less than 0 mg/mL and less than 0.05 mg/mL. At least part of a section of the housing that is in contact with the protein solution formulation is formed of a resin including either or both of a hydrogenated cycloolefin ring-opened polymer and a copolymer of a cycloolefin and a chain olefin.

A therapeutic pouch is provided. The therapeutic pouch defines a cavity for slidably receiving intravenous therapy equipment, such as an IV bag or other fluid dispenser. A front portion of the therapeutic pouch provides a comforting presentation for the patient, while the rear portion of the therapeutic pouch provides a visibility pouch for securing the IV bag and allowing a healthcare provider visibility of the administration of the fluids retained by the IV bag. The visibility pouch may provide an upper opening and an opposing lower opening, both communicating with the cavity for enabling the IV bag to protrude therefrom and access to IV tubing and ports, respectively. An upper portion of the therapeutic pouch provides a hanging loop for working in unison with the IV bag hole for enabling support from an IV stand or the like.

A cap and container assembly includes a container having a base and a side wall extending upward from the base. The base and the side wall define an interior, and the side wall defines an opening leading to the interior. A cap moves with respect to the container between an opened position in which the opening is exposed, and a closed position in which the cap covers the opening. A tab projects outward from the cap and has a bottom surface. A spacer projects from the container side wall at a location beneath the tab when the assembly is in the closed position. The spacer bends inward towards the container in response to application of a sufficient force, to move from a locked position that blocks the bottom surface of the tab, to an unlocked position to expose at least a portion of the bottom surface of the tab.

A functional food including a supplement composition in which the supplement composition includes a non-winterized marine source oil.

An illustrated view of an exemplary emergency kit for use in an emergency medical condition and a method for automating the ordering of the emergency kits for dentist is presented. The emergency kit is useful for providing short-term medical relief in an emergency while waiting for ambulance or other emergency medical personnel to arrive at the scene. The emergency kit provides a useful medical syringe for use by a dentist in a mouth of a patient experiencing an emergency medical condition.

The invention relates to a method of reducing or preventing the adsorption of a polypeptide on a surface, or the aggregation of a polypeptide in a liquid composition in contact with a surface comprising the steps of a) providing a composition comprising the polypeptide and at least two different amino acids; b) contacting the composition with the surface. Furthermore, the invention relates to medical devices comprising a composition comprising the polypeptide and at least two different amino acids.

A biopharmaceutical flow port, a biopharmaceutical liquid container assembly, and a method for manufacturing the biopharmaceutical flow port and the biopharmaceutical liquid container assembly are described. The biopharmaceutical flow port includes a hose barb coupled to an elliptic body. The hose barb includes a bore. The elliptic body includes a flow passage, a first edge, and a second edge. The flow passage is fluidly coupled to the bore. The first edge extends from the elliptic body away from the flow passage in a first direction and the second edge extends from the elliptic body away from the flow passage in a second direction opposite the first direction. The biopharmaceutical liquid container assembly includes a biopharmaceutical liquid container with an opening and the biopharmaceutical flow port coupled to the biopharmaceutical liquid container within the opening and in fluid communication with a volume of the biopharmaceutical liquid container.

A kit preparation that enables drug dose adjustment. The kit preparation includes a bag which contains an infusion solution or pure water and at least one drug enclosing part in which a drug is enclosed and which is provided with a sealing part. The drug enclosing part is connected to the bag via the sealing part; and, when the sealing part is released, the bag is communicated with the drug enclosing part and thus the drug is poured into the bag so that a dispensing work can be carried out.

The present invention relates to a medical device having a transparent region and a label wherein a hot stamping film is located on the transparent region; and a thermal transfer film that in turn has a label is located on the hot stamping film, with the label having a different color than the hot stamping film. The invention furthermore relates to a method of applying a label to a medical device.

An IV adapter to allow for the mixing of multiple compatible medications with one another using a single bag of intravenous fluid. The IV adapter has multiple arms extending which gives rise to the ability to mix multiple medications. There is a spike within each arm to puncture the medication. The plurality of arms have built in mechanisms to control the flow of the medication and stop it from flowing in a certain direction. There are connections at the end of each arm allowing for a tight seal to be made to prevent any medication from leaking out of the IV line.